Kim Kwang Kyoun, Won Yougun, Won Ye Yeon
Department of Orthopedic Surgery, Stanford University College of Medicine (Visiting professor), Stanford, CA, USA.
Department of Orthopaedic Surgery, Konyang University School of Medicine, Deajeon, Korea.
Yonsei Med J. 2016 Sep;57(5):1209-13. doi: 10.3349/ymj.2016.57.5.1209.
The aim of this study was to investigate the efficacy of low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in Korean patients who underwent hip fracture surgery (HFS).
Prospectively, a total 181 cases were classified into the LMWH user group (116 cases) and LMWH non-user group (65 cases). Each group was sub-classified according to fracture types as follows: 81 cases of intertrochanteric fracture (group A: 49, group B: 32) and 100 cases of neck fracture (group C: 67, group D: 33). We compared the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) according to LMWH use.
Of the 181 cases, four DVTs were found in the LMWH user groups (1 in group A, and 3 in group C). One case of PE was found in LMWH non-user group D. The incidences of DVT and PE showed no statistically significant differences between the LMWH user and non-user groups (p=0.298 and 0.359, respectively). In subgroup analysis, no statistically significant differences were found between groups A and B and between groups C and D.
The administration of LMWH was not effective in the prevention of venous thromboembolism and PE in the Korean patients who underwent HFS.
本研究旨在调查低分子量肝素(LMWH)对接受髋部骨折手术(HFS)的韩国患者预防静脉血栓栓塞的疗效。
前瞻性地将总共181例患者分为LMWH使用组(116例)和LMWH非使用组(65例)。每组根据骨折类型进一步细分如下:转子间骨折81例(A组:49例,B组:32例)和股骨颈骨折100例(C组:67例,D组:33例)。我们比较了使用LMWH与否的深静脉血栓形成(DVT)和肺栓塞(PE)的发生率。
在181例患者中,LMWH使用组发现4例DVT(A组1例,C组3例)。LMWH非使用组D发现1例PE。LMWH使用组和非使用组之间的DVT和PE发生率无统计学显著差异(p分别为0.298和0.359)。在亚组分析中,A组和B组之间以及C组和D组之间未发现统计学显著差异。
对于接受HFS的韩国患者,使用LMWH预防静脉血栓栓塞和PE无效。